期刊文献+

细胞凋亡相关基因在膀胱移行细胞癌中表达的意义 被引量:1

THE EXPRESSIONS OF P53、BCL2 AND BAX IN TRANSITIONAL CELL CARCINOMA OF BLADDER
暂未订购
导出
摘要 目的 :探讨与细胞凋亡关系最为密切的三个基因 P5 3、BCL2及 BAX在膀胱移行细胞癌中的表达与其病理分级及预后的关系。方法 :采用 P5 3、BCL2单克隆抗体及 BAX多克隆抗体 ,对 70例膀胱移行细胞癌和 1 0例膀胱炎石蜡切片进行免疫组织化学染色。结果 :P5 3蛋白的阳性表达率在各级别间及复发与未复发组间的差异有统计学意义 ( P <0 .0 5或 P <0 .0 1 ) ;BCL2在 级肿瘤的阳性表达率 ( 4 4.4% )明显高于 级 ( 3 .5 % )的表达率 ( P <0 .0 5 ) ;BAX的阳性表达率在 级 ( 2 2 .2 % )则明显低于 ( 86.2 % )、 级 ( 73 .9% )的表达率 ( P <0 .0 5 ) ,BAX的阳性表达率在膀胱良恶性病变间无明显差异 ( P >0 .0 5 ) ;二者在复发组的阳性表达率明显高于未复发组 ( P <0 .0 5 ) ;BCL2 /BAX及与 P5 3三者的共同表达情况与肿瘤的恶性程度呈正相关 (均 P <0 .0 5 ) ,与预后无相关性 ( P >0 .0 5 )。结论 :P5 3、BCL2及 BAX的阳性表达可以在一定程度上反映膀胱移行细胞癌恶性程度的增加及临床预后不良 ,三者可能通过对细胞凋亡的调节从而影响肿瘤恶性性状的发展。 Objective: To investigate the expression of P53、BCL2 and BAX in 70 transitional cell carcinomata of bladder (TCCB) and 10 cystitis. Methods: P53、BCL2 and BAX expression were assayed by means of immunohistochemical S-P method. Results: The positive rate of P53 protein expression was related to grade and prognosis (P<0.05 or P<0.01); There was statistically significant difference between grade Ⅰ tumor and grade Ⅲ for the positive rate of BCL2 protein expression (P<0.01). The difference between grade Ⅲ andⅠ、Ⅱ was significant for the expression of BAX protein. The expression of BCL2 and BAX were related to the tumor prognosis (P<0.05). The common expression of BCL2/BAX or P53、BCL2/BAX were corelated to grade of tumor (P<0.05). Conclusion: Expression of P53、BCL2 and BAX is a helpful index in predicating grade and prognosis of TCCB, and the progression of TCCB can be related to P53、BCL2 and BAX apoptosis function to tumor cells.
出处 《内蒙古医学院学报》 2003年第4期226-230,共5页 Acta Academiae Medicinae Neimongol
关键词 膀胱移行细胞癌 细胞凋亡 P53 BCL2 BAX 免疫组化 transitional cell carcinoma of bladder apoptosis P53 BCL2 BAX immunohistochemistry
  • 相关文献

参考文献14

  • 1Chen TM, Defendi V. Functional interaction of P53 with HPV18 E6, c-myc and H-ras in 3T3 cell [J].Oncogene, 1994 ;7(8): 1541
  • 2梁英杰,凌启波.一种快速高敏感的免疫组织化学染色法—LSAB法[J].中华病理学杂志,1993,22(6):369-369. 被引量:71
  • 3Hollstein M, Sidransky D, Vogelstein, et al. P53 mutations in human cancers[J]. Science, 1991; 253(5015):49
  • 4Fujimot K, Yamada, Y, Okajima E. Frequent association of p53 gene mutation in invasive bladder cancer[J]. Cancer res, 1992;52(6) :1393
  • 5Williams GN. Apoptosis in the immune system[J]. J Pathol, 1994;173:1
  • 6Gaular D. Expression of the bcl-2 gene product in follicular lymphoma[J]. Am J Pathol, 140:1089
  • 7朱建善,杨玖生,沈峥嵘,唐美芳.肾细胞癌bc1-2、P53、ER、PR的表达及临床意义[J].中华泌尿外科杂志,1996,17(10):586-588. 被引量:6
  • 8King ED, Matteson J, Jacobss, et al. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: assocition with tumor progression[J]. J Urol, 1996; 155(1):316
  • 9皋岚湘,丁华野.Bcl-2基因与恶性肿瘤[J].国外医学(生理病理科学与临床分册),1996,16(2):69-72. 被引量:19
  • 10Zoltan N. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death[J]. Cell, 1993;74:609

二级参考文献1

  • 1赵波,中华泌尿外科杂志,1995年,8卷,457页

共引文献95

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部